Diabetologia , 65(4), 578-587
If you suspect that semaglutide or any other medication is affecting your menstrual cycle, do not hesitate to seek professional advice
GLP-1 Multi-District Litigation | Updates And What You Need To Know Jun 28, 2025 4 min read The wave of lawsuits involving GLP-1 receptor agonistssuch as Ozempic, Wegovy, Trulicity, and Mounjarohas evolved into one of the most closely watched mass torts in the country
Long before it was regarded as a so-called "miracle" drug, Ozempic attracted the attention of obesity medicine specialists after extensive clinical trials in 2017 revealed weight loss was a significant side effect of the medication
Study Results The researchers in this study, who currently receive JDRF funding (via JDRF International in the United States) to investigate the use of semaglutide later in disease to assist with glycemic control, administered the drug to 10 individuals